# Targeting Inflammation With Salsalate in Type 1 Diabetes Neuropathy

> **NCT02936843** · PHASE2,PHASE3 · COMPLETED · sponsor: **University of Michigan** · enrollment: 61 (actual)

## Conditions studied

- Type 1 Diabetes
- Peripheral Neuropathy

## Interventions

- **DRUG:** Salsalate
- **DRUG:** PLACEBO

## Key facts

- **NCT ID:** NCT02936843
- **Lead sponsor:** University of Michigan
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-10
- **Primary completion:** 2023-05-01
- **Final completion:** 2023-05-01
- **Target enrollment:** 61 (ACTUAL)
- **Last updated:** 2025-05-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02936843

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02936843, "Targeting Inflammation With Salsalate in Type 1 Diabetes Neuropathy". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT02936843. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*